Literature DB >> 24447376

Performance on the Wechsler Adult Intelligence Scale-III in Japanese patients with schizophrenia.

Haruo Fujino1, Chika Sumiyoshi, Tomiki Sumiyoshi, Yuka Yasuda, Hidenaga Yamamori, Kazutaka Ohi, Michiko Fujimoto, Satomi Umeda-Yano, Arisa Higuchi, Yumiko Hibi, Yukako Matsuura, Ryota Hashimoto, Masatoshi Takeda, Osamu Imura.   

Abstract

AIM: Patients with schizophrenia have been reported to perform worse than non-schizophrenic populations on neuropsychological tests, which may be affected by cultural factors. The aim of this study was to examine the performance of a sizable number of patients with schizophrenia on the Japanese version of the Wechsler Adult Intelligence Scale-III (WAIS-III) compared with healthy controls.
METHODS: Performance on the WAIS-III was evaluated in 157 Japanese patients with schizophrenia and in 264 healthy control subjects.
RESULTS: All IQ scores and four indices from the WAIS-III were impaired for patients with schizophrenia compared with healthy controls. Processing Speed was markedly disturbed, approximately 2 SD below that of the healthy control group. Among the 13 subtests, Comprehension (z = -1.70, d = 1.55), Digit Symbol Coding (z = -1.84, d = 1.88), and Symbol Search (z = -1.85, d = 1.77) were profoundly impaired relative to the healthy controls.
CONCLUSION: These results indicate that the pattern and degree of impairment, as evaluated by the WAIS-III, in Japanese patients are similar to those previously reported in English-speaking patients and that the deficits of some neuropsychological domains relevant to functional outcomes are universally characteristic of schizophrenia.
© 2014 The Authors. Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  Wechsler Adult Intelligence Scale-III; cognitive impairment; cross-national difference; functional outcome; schizophrenia

Mesh:

Year:  2014        PMID: 24447376     DOI: 10.1111/pcn.12165

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  17 in total

1.  Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study.

Authors:  Daisuke Koshiyama; Masaki Fukunaga; Naohiro Okada; Fumio Yamashita; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Kazutaka Ohi; Haruo Fujino; Yoshiyuki Watanabe; Kiyoto Kasai; Ryota Hashimoto
Journal:  Transl Psychiatry       Date:  2018-01-10       Impact factor: 6.222

Review 2.  Postural Sway and Clinical Characteristics in Patients with Psychotic Disorders: A Review.

Authors:  Haruo Fujino; Osamu Imura
Journal:  Psychiatr Q       Date:  2015-12

3.  A Retrospective Study on the Relationship Between Cognitive Function and Social Function in Patients With Schizophrenia.

Authors:  Takamitsu Shimada; Genyo Kobayashi; Yoshihiro Saeki; Chikako Mizukoshi; Kazuo Chikazawa; Katsutoshi Nokura; Mitsuru Hasegawa; Tamami Maeda; Yoshiki Maeda; Yasuhiro Kawasaki
Journal:  J Clin Med Res       Date:  2022-09-29

4.  Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood.

Authors:  Yumi Shirai; Yuko Fujita; Ryota Hashimoto; Kazutaka Ohi; Hidenaga Yamamori; Yuka Yasuda; Tamaki Ishima; Hiroyuki Suganuma; Yusuke Ushida; Masatoshi Takeda; Kenji Hashimoto
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

5.  Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.

Authors:  Yoshiyuki Watanabe; Hisashi Tanaka; Akio Tsukabe; Yuki Kunitomi; Mitsuo Nishizawa; Ryota Hashimoto; Hidenaga Yamamori; Michiko Fujimoto; Masaki Fukunaga; Noriyuki Tomiyama
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

6.  Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects.

Authors:  Yoshihiro Kamada; Ryota Hashimoto; Hidenaga Yamamori; Yuka Yasuda; Tetsuo Takehara; Yuko Fujita; Kenji Hashimoto; Eiji Miyoshi
Journal:  BBA Clin       Date:  2016-02-23

7.  Role of subcortical structures on cognitive and social function in schizophrenia.

Authors:  Daisuke Koshiyama; Masaki Fukunaga; Naohiro Okada; Fumio Yamashita; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Kazutaka Ohi; Haruo Fujino; Yoshiyuki Watanabe; Kiyoto Kasai; Ryota Hashimoto
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

8.  Predicting employment status and subjective quality of life in patients with schizophrenia.

Authors:  Haruo Fujino; Chika Sumiyoshi; Tomiki Sumiyoshi; Yuka Yasuda; Hidenaga Yamamori; Kazutaka Ohi; Michiko Fujimoto; Ryota Hashimoto; Masatoshi Takeda; Osamu Imura
Journal:  Schizophr Res Cogn       Date:  2015-12-07

Review 9.  A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient.

Authors:  Kazutaka Ohi; Chika Sumiyoshi; Haruo Fujino; Yuka Yasuda; Hidenaga Yamamori; Michiko Fujimoto; Tomiki Sumiyoshi; Ryota Hashimoto
Journal:  Front Psychiatry       Date:  2017-12-22       Impact factor: 4.157

10.  The Relationship between Cognitive Decline and Psychopathology in Patients with Schizophrenia and Bipolar Disorder.

Authors:  Moon-Doo Kim; Hye-Jin Seo; Hyun-Ju Yun; Young-Eun Jung; Joon Hyuk Park; Chang-In Lee; Ji Hyun Moon; Seong-Chul Hong; Bo-Hyun Yoon; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.